Related references
Note: Only part of the references are listed.Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Roberta Cascella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic alpha-synuclein oligomers in Parkinson's disease
Nouara Yahi et al.
GLYCOCONJUGATE JOURNAL (2022)
Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology
Takeshi Kawarabayashi et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease
Berenice A. Gutierrez et al.
BIOMEDICINES (2022)
Development and Regulatory Challenges for Peptide Therapeutics
Doris Zane et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2021)
A Global Review on Short Peptides: Frontiers and Perspectives
Vasso Apostolopoulos et al.
MOLECULES (2021)
Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
Assou El-Battari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Intranasal Administration of PACAP Is an Efficient Delivery Route to Reduce Infarct Volume and Promote Functional Recovery After Transient and Permanent Middle Cerebral Artery Occlusion
Asma Cherait et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prediction of Transmembrane Regions, Cholesterol, and Ganglioside Binding Sites in Amyloid-Forming Proteins Indicate Potential for Amyloid Pore Formation
Katja Venko et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Membrane Interactions and Toxicity by Misfolded Protein Oligomers
Mario Gonzalez-Garcia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
Martin Tolar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Insights into Structure and Aggregation Behavior of Elastin-like Polypeptide Coacervates: All-Atom Molecular Dynamics Simulations
Nan K. Li et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2021)
The biological pathways of Alzheimer disease: a review
Marco Calabro et al.
AIMS NEUROSCIENCE (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Aβ-ganglioside interactions in the pathogenesis of Alzheimer's disease
Katsumi Matsuzaki
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Evolving a Peptide: Library Platforms and Diversification Strategies
Kristof Bozovicar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Toxicity and Polymorphism of β-Amyloid Oligomers
Ya-ru Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Unroofing site-specific alpha-synuclein-lipid interactions at the plasma membrane
Upneet Kaur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Jacques Fantini et al.
PROTEIN SCIENCE (2020)
Models of the blood-brain barrier using iPSC-derived cells
Louise Delsing et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2020)
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
Simonetta Sipione et al.
FRONTIERS IN NEUROSCIENCE (2020)
Sequence and structure-based peptides as potent amyloid inhibitors: A review
Amit Mitra et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Liraglutide and its Neuroprotective PropertiesFocus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events
Michal Wicinski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Andy Chi-Lung Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts
Camila Fabiani et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers
Lauren K. Rudenko et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
GM1 Ganglioside role in the interaction of Alpha-synuclein with lipid membranes: Morphology and structure
F. Perissinotto et al.
BIOPHYSICAL CHEMISTRY (2019)
Therapeutic peptides for CNS indications: Progress and challenges
Bruce H. Morimoto
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Peptides as Potential Therapeutics for Alzheimer's Disease
Samo Ribaric
MOLECULES (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Cell penetrating peptides: A concise review with emphasis on biomedical applications
Hossein Derakhshankhah et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
THE AMYLOID HYPOTHESIS ON TRAIL
Simon Makin
NATURE (2018)
Evaluation of intranasal delivery route of drug administration for brain targeting
Franciska Erdo et al.
BRAIN RESEARCH BULLETIN (2018)
Spatial Relationship and Functional Relevance of Three Lipid Domain Populations at the Erythrocyte Surface
Louise Conrard et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer's Disease: Stability and Delivery to the Brain
Nazneen N. Dewji et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes
David C. Bode et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
Ting Yang et al.
JOURNAL OF NEUROSCIENCE (2017)
Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease
Ghada A. Badawi et al.
INFLAMMOPHARMACOLOGY (2017)
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Boettger et al.
PLOS ONE (2017)
THPdb: Database of FDA-approved peptide and protein therapeutics
Salman Sadullah Usmani et al.
PLOS ONE (2017)
Role of membrane GM1 on early neuronal membrane actions of Aβ during onset of Alzheimer's disease
E. J. Fernandez-Perez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Alpha-synuclein oligomers: a new hope
Nora Bengoa-Vergniory et al.
ACTA NEUROPATHOLOGICA (2017)
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
Emma Deas et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Prediction of cell-penetrating peptides with feature selection techniques
Hua Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides
Coralie Di Scala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
Liqin Qi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Gangliosides of the Vertebrate Nervous System
Ronald L. Schnaar
JOURNAL OF MOLECULAR BIOLOGY (2016)
Alpha-Synuclein Oligomers-Neurotoxic Moleculesin Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
FRONTIERS IN NEUROSCIENCE (2016)
Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein
Coralie Di Scala et al.
SCIENTIFIC REPORTS (2016)
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
M. Elizabeth Meredith et al.
AAPS JOURNAL (2015)
GM1 ganglioside and Alzheimer's disease
Katsuhiko Yanagisawa
GLYCOCONJUGATE JOURNAL (2015)
NEUROPROTECTIVE EFFECTS OF LIXISENATIDE AND LIRAGLUTIDE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
W. Liu et al.
NEUROSCIENCE (2015)
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Dana Maria Copolovici et al.
ACS NANO (2014)
A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease
Eric Karran et al.
ANNALS OF NEUROLOGY (2014)
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Edward Rockenstein et al.
BRAIN (2014)
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
Joana Bicker et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Quantitative analysis of drug delivery to the brain via nasal route
Luba Kozlovskaya et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
Soyon Hong et al.
NEURON (2014)
Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide
Nouara Yahi et al.
PLOS ONE (2014)
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics
William F. Goure et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Li-Li Zou et al.
CURRENT NEUROPHARMACOLOGY (2013)
Alzheimer's disease: which type of amyloid-preventing drug agents to employ?
Hyunbum Jang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2013)
Alzheimer's disease (AD) as a disorder of the plasma membrane
Walter J. Lukiw
FRONTIERS IN PHYSIOLOGY (2013)
Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation
Jacques Fantini et al.
FRONTIERS IN PHYSIOLOGY (2013)
Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes
Felix Schmidt et al.
PLOS ONE (2012)
Effect of intranasal arginine vasopressin on human headache
Jun Yang et al.
PEPTIDES (2012)
Clinical Course of Patients with Familial Early-Onset Alzheimer's Disease Potentially Lacking Senile Plaques Bearing the E693 Delta Mutation in Amyloid Precursor Protein
Hiroyuki Shimada et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
Systemic and Direct Nose-to-Brain Transport Pharmacokinetic Model for Remoxipride after Intravenous and Intranasal Administration
Jasper Stevens et al.
DRUG METABOLISM AND DISPOSITION (2011)
Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
Jacques Fantini et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
Hyunbum Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer
Rakez Kayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A New Minimal-Stress Freely-Moving Rat Model for Preclinical Studies on Intranasal Administration of CNS Drugs
Jasper Stevens et al.
PHARMACEUTICAL RESEARCH (2009)
A new amyloid μ variant favoring oligomerization in Alzheimer's-type dementia
Takami Tomiyama et al.
ANNALS OF NEUROLOGY (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
Fernanda G. De Felice et al.
NEUROBIOLOGY OF AGING (2008)
The binding constant for amyloid Aβ40 peptide interaction with human serum albumin
Malgorzata Rozga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Intranasally delivered TGF-β1 enters brain and regulates gene expressions of its receptors in rats
Yu-Ping Ma et al.
BRAIN RESEARCH BULLETIN (2007)
Metabolism of cydiastatin 4 and analogues by enzymes associated with the midgut and haemolymph of Manduca sexta larvae
Neil Audsley et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2007)
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Carles Gaig et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia
BJ Tabner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice
R De Rosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
alpha-Synuclein pathology does not predict extrapyramidal symptoms or dementia
L Parkkinen et al.
ANNALS OF NEUROLOGY (2005)
Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model
JL Brunet et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
TM Ross et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies
Y Omidi et al.
BRAIN RESEARCH (2003)
In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues
KP Kokko et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
C Colosimo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease
C Adessi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Share Paper
